Sh. Chou et al., EVIDENCE FOR THE INVOLVEMENT OF CATECHOLAMINES IN THE 2-DG-INDUCED IMMUNOMODULATORY EFFECTS IN SPLEEN, Brain, behavior, and immunity, 11(2), 1997, pp. 79-93
The role of catecholamines in immune changes associated with the metab
olic stress of 2-deoxy-D-glucose (2-DG) was examined in this study. Ma
le Lewis rats were pretreated with the nonselective beta-adrenergic re
ceptor antagonist nadolol (0-0.5 mg/kg) and then received either a sal
ine or 2-DG (500 mg/kg) injection. Nadolol attenuated the 2-DG-induced
suppression of splenic T-cell mitogenic response and interferon-gamma
production and increased nitric oxide production by macrophages in a
dose-dependent manner. Conversely, nadolol did not attenuate the 2-DG-
induced changes in immune parameters in peripheral blood leukocytes. T
hese results suggest that the peripheral release of catecholamines is
responsible for 2-DG induced splenic immune alterations, whereas the p
eripheral release of catecholamine is not responsible for 2-DG-induced
blood immune alterations. Furthermore, the neuroendocrine mechanisms
responsible for splenic immune changes induced by the metabolic stress
of 2-DG administration were the same as those involved in immune chan
ges induced by physical and psychological stress. Thus, this study sug
gests that common neuroendocrine pathways exist for several types of s
tress-induced immunomodulations. (C) 1997 Academic Press.